Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Fisher, David
Item TypeName
Academic Article BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.
Academic Article Melanoma: from mutations to medicine.
Academic Article Developing melanoma therapeutics: overview and update.
Academic Article Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function.
Academic Article An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Academic Article An oncogenic role for ETV1 in melanoma.
Academic Article New strategies in metastatic melanoma: oncogene-defined taxonomy leads to therapeutic advances.
Academic Article BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.
Academic Article Oncogenic BRAF regulates oxidative metabolism via PGC1a and MITF.
Academic Article BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
Concept Proto-Oncogene Proteins B-raf
Academic Article Melanoma and viagra: an unexpected connection.
Academic Article Molecular pathways: BRAF induces bioenergetic adaptation by attenuating oxidative phosphorylation.
Academic Article Isolation and molecular characterization of circulating melanoma cells.
Academic Article Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade.
Academic Article Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics.
Academic Article A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
Academic Article UV and melanoma: the TP53 link.
Academic Article BRAF and MC1R in melanoma: different in head and neck tumors?
Academic Article Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
Academic Article Melanoma.
Academic Article Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.
Academic Article The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth.
Academic Article Microphthalmia-associated transcription factor phosphorylation: Cross talk between GSK3 and MAPK signaling.
Academic Article Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies.
Search Criteria
  • Proto Oncogene Proteins B raf
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.